文献速递免疫规划慢病防控与筛查

免疫抑制剂对肺炎球菌疫苗免疫原性影响的系统综述与Meta分析

The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2018-08-16

该系统综述与Meta分析纳入22篇文章共2077例患者,其中1623例接受免疫抑制剂治疗、454例为对照,评估硫唑嘌呤、甲氨蝶呤、抗TNFα或利妥昔单抗对自身免疫病患者肺炎球菌疫苗初次血清学应答的影响。结果显示,与对照相比,接受免疫抑制剂治疗的患者对肺炎球菌结合疫苗(PCV)和肺炎球菌多糖疫苗(PPSV)的初次血清学应答均受损,且PCV后受损较PPSV更明显;抗TNFα治疗者的应答较其他免疫抑制剂治疗者更有利。

要点

  • 接受免疫抑制剂治疗的患者对PCV和PPSV的初次血清学应答均受损。
  • PCV后血清学应答受损较PPSV更明显,作者假设与细胞免疫受损有关。
  • 抗TNFα治疗者的应答较其他免疫抑制剂治疗者更有利。

核心结论

  • 在自身免疫病患者中,与对照相比,接受免疫抑制剂治疗者对PCV和PPSV的初次血清学应答均受损,且PCV后受损较PPSV更明显。
  • 抗TNFα治疗者的应答较其他免疫抑制剂治疗者更有利。

研究设计与样本

  • PROSPERO注册(CRD42017058364)的系统综述与Meta分析,纳入22篇文章共2077例患者,其中1623例接受免疫抑制剂治疗、454例为对照。

主要发现

  • 与对照相比,接受免疫抑制剂治疗的患者对PCV和PPSV的初次血清学应答均受损。
  • 该应答受损在PCV后较PPSV后更明显。
  • 抗TNFα治疗者的应答较其他免疫抑制剂治疗者更有利。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要采用统一保护相关物的针对性研究来填补该患者群体疫苗免疫学知识空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with a weakened immune system due to immunosuppressive treatment are at increased risk of infection with Streptococcus pneumoniae. Although pneumococcal vaccination is highly recommended for those patients, the effectiveness of pneumococcal vaccination in this population remains largely unknown. Therefore, the objective of this PROSPERO-registered systematic review and meta-analysis was to evaluate the effect of the most commonly prescribed immunosuppressive agents such as azathioprine, methotrexate, anti-Tumor Necrosis Factor α (TNFα), or rituximab, on the initial serologic response to pneumococcal vaccination in patients with auto-immune disease. METHODS: We included 22 articles comprising 2077 patients, of whom 1623 were treated with immunosuppressive agents, and 454 were controls. RESULTS AND DISCUSSION: The findings of our systematic review indicate that, in patients treated with immunosuppressive medication and compared to controls, the initial serologic response to pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPSV) are impaired. Moreover, this impaired response was more profound after PCV than after PPSV. We hypothesize that the immunosuppressive medication mainly compromises the cellular immunity, explaining the more severely reduced response rate to PCV (which induces a T-cell dependent immune response), compared to PPSV. Treatment with TNFα blocking agents was associated with a more favorable response, compared to patients treated with other immunosuppressive medication. Targeted research applying uniform correlates of protection is needed to bridge the knowledge gap in vaccination immunology in this patient group. PROSPERO registration: CRD42017058364.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van Aalst M, Langedijk AC, Spijker R, et al. The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis. Vaccine. 2018. PMID: 30122649. doi:10.1016/j.vaccine.2018.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。